Nexafed gains national distribution

PALATINE, Ill. — Acura Pharmaceuticals on Monday announced that Nexafed, its next generation pseudoephedrine with abuse-deterrent technology, will now be stocked by Rite Aid.

Nexafed is a 30 mg immediate-release pseudoephedrine product that combines nasal-congestion relief with a unique technology that disrupts the conversion of pseudoephedrine into methamphetamine.

In September, the American Journal of Drug and Alcohol Abuse published a study that validates the ability of Nexafed to uniquely disrupt the extraction and conversion of pseudoephedrine into methamphetamine. The study also confirmed that Nexafed delivers the same efficacy compared to other similar PSE products.